Alexandria, Va. - Donald J. Abraham, Ph.D., professor and department chair of medicinal chemistry and director of the Institute for Structural Biology and Drug Discovery at Virginia Commonwealth University, has been selected by the AACP Board of Directors as the recipient of the 2002 AACP Paul Dawson Biotechnology Award and will be honored in Kansas City, Missouri, during the annual meeting awards banquet on July 16.
The award, sponsored by Amgen Inc.
, consists of a double helix glass sculpture and a $10,000 cash prize.He
will also present an address at a special session on July 16.Dr. Abraham
becomes the 10th winner of the Paul Dawson Biotechnology Award.Professor Abraham has had a highly productive and distinguished career and has consistently made significant contributions in instruction, research, and scholarly activity.Dr. Abraham
has published over 130 publications in peer-reviewed journals and has received almost $9 million in extramural funding during his
was a visiting professor at the Medical Research Council Laboratory of Molecular Biology in Cambridge, UK, working with the founder of that laboratory, Max Perutz, and the University of Parma
also won a Humboldt-Stiftung Award to work in the Max Plank Institute for Biochemistry
in Munich-Martinsreid, Germany and the School of Pharmacy at the University of Munich
An early leader in the area of anti-gelling agents to treat sickle cell anemia, Dr. Abraham
is recognized nationally and internationally for his
research on allosteric effectors of hemoglobin.
...Professor Abraham was instrumental in bringing the area of biotechnology into the pharmacy curriculum at Virginia Commonwealth University, where he has been a faculty member since 1988, and, more importantly, into the curricula of other programs within the University.His
course in molecular modeling is taken by graduate students from many different disciplines and is one of the most popular graduate courses in the University.Dr. Abraham
is one of the original crafters of the Virginia Bioinformatics Consortium, a statewide bioinformatics partnership of VCU, University of Virginia, Virginia Tech, and Georgia Mason University
.He is the co-founder of EduSoft LC, a software company that specializes in drug design software and founder of a new biotechnology company, Allos Therapeutics, Inc.He serves as editor of Burger's Medicinal Chemistry, 6th Edition, and has designed a new textbook on drug discovery.Recently, Dr. Abraham was appointed by the Governor of the Commonwealth of Virginia as a member of the Alzheimer's Disease and Related Disorders Commission and the Virginia Research and Technology Advisory Commission.